ArticleCell biology and toxicology2026
N-nitrosodimethylamine induces cytochrome P450 activation but not epithelial remodeling in well-differentiated human airway epithelial cells.
Article in Cell biology and toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
N-nitrosodimethylamine (NDMA) is a volatile environmental contaminant formed from diverse precursor chemicals widely present in byproducts of industrial processes, personal care products, and pharmaceuticals. Therefore, NDMA is frequently detected in both indoor and outdoor air. However, its potential risk from inhalation exposure has been largely underestimated and the mechanisms underlying its toxicity remain insufficiently studied. To address this knowledge gap, we investigated the effects of NDMA on primary human bronchial epithelial (HBE) cells differentiated in air-liquid interface cultures, a physiologically relevant in vitro model that mimics the structure and function of the human airway epithelium. To determine time and dose-dependent responses, we exposed well-differentiated HBE cells to NDMA at increasing concentrations (0.05 - 5 mM) either basolaterally for up to 24 h or apically for 4 h daily over 1, 3, or 5 days. We then assessed cellular responses linked to epithelial cell functions, including cell viability, epithelial-to-mesenchymal transition (EMT), epithelial junction integrity, and xenobiotic metabolism, focusing on cytochrome P450 (CYP450) enzyme. NDMA exposure at concentrations up to 5 mM did not affect cell viability under any tested conditions. Similarly, we observed no evidence of EMT, as determined by mRNA expression of vimentin and ZEB1, and no disruption of epithelial junctions, as indicated by preserved expression and localization of E-cadherin and ZO-1. In contrast, 5 mM NDMA significantly increased mRNA expression and enzymatic activity of CYP450 in a time-dependent manner over 5 days. Together these data indicate that NDMA activates epithelial metabolic pathways in the absence of EMT or epithelial remodeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.